Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Genprex Inc (NQ: GNPX )

3.750 USD -0.080 (-2.09%)
Official Closing Price Updated: 7:57 PM EST, Jan 15, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Genprex Inc

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
28 Stocks Moving In Monday's Pre-Market Session
Gainers Avalon Holdings Corporation (NYSE: AWX) rose 93.2 percent to $19.80 in pre-market trading after climbing 80.14 percent on ... 
Tags Movers SIGM SOHU
From Benzinga
62 Biggest Movers From Friday
Gainers SSLJ.com Limited (NASDAQ: SSLJ) shares climbed 125.79 percent to close at $1.35 on Friday. Avalon Holdings Corporation ... 
Tags NBRV CLUB ACIU
From Benzinga
Benzinga's Biggest Movers For The Week Of July 23, 2018
The data presented below was compiled using a Screener widget and a Newsfeed widget on the Benzinga Pro platform. The Screener is ... 
Tags SXE Benzinga Market News
From Benzinga
55 Stocks Moving In Friday's Mid-Day Session
Gainers SSLJ.com Limited (NASDAQ: SSLJ) shares jumped 120.8 percent to $1.32. Cherokee Inc. (NASDAQ: CHKE) shares rose 29.5 ... 
Tags BOOM CMG OPRA
From Benzinga
Genprex Enters Agreement with the University of Texas MD Anderson Cancer Center to Study Oncoprex in Combination with Immunotherapies
Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, has entered a Sponsored Research... 
From Business Wire News Releases
Genprex To Present At The Singular Research Summer Solstice 2018 Conference
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, today announced that Rodney Varner,... 
From PR Newswire
Diamond Equity Research Initiates Coverage on Genprex Inc. (NASDAQ: GNPX) with a Valuation of $13 Per Share
via NetworkWire – Diamond Equity Research, a leading equity research and corporate access firm with a focus on small capitalization public companies has initiated coverage of Genprex Inc.... 
From GlobeNewswire News Releases
54 Biggest Movers From Yesterday
Gainers China Lending Corporation (NASDAQ: CLDC) shares jumped 145.55 percent to close at $4.69 on Tuesday. Ascent Capital ... 
Tags EXEL GE CADC
From Benzinga
40 Stocks Moving In Tuesday's Mid-Day Session
Gainers China Lending Corporation (NASDAQ: CLDC) shares climbed 96.4 percent to $3.7499. Ability Inc. (NASDAQ: ABIL) surged ... 
Tags Consumer Staples EXEL GE
From Benzinga
26 Stocks Moving In Tuesday's Pre-Market Session
Gainers Lee Enterprises, Incorporated (NYSE: LEE) rose 37.5 percent to $3.30 in pre-market trading following news that it will ... 
Tags AGEN Publishing JKS
From Benzinga
Genprex Selects 4Clinics To Provide Clinical And Regulatory Support For Oncoprex Development Program
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, has selected 4Clinics Group Sprl to... 
From PR Newswire
48 Biggest Movers From Yesterday
Gainers Astrotech Corporation (NASDAQ: ASTC) shares surged 217.44 percent to close at $6.1901 on Tuesday after the ... 
Tags SMAR SRRK GRBK
From Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Astrotech Corporation (NASDAQ: ASTC) jumped 209.7 percent to $6.04 after the company’s subsidiary, 1st Detect, ... 
Tags CBIO SPRO GEVO
From Benzinga
58 Biggest Movers From Yesterday
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in ... 
Tags KEYS VTVT SCPH
From Benzinga
44 Stocks Moving In Thursday's Mid-Day Session
Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) jumped 124.8 percent to $243.725 in reaction to an encouraging Phase 2 ... 
Tags CMD Trading Ideas VCEL
From Benzinga
Genprex Engages WIRB-Copernicus Group, Inc. To Provide Clinical Trial Services To Support Oncoprex Clinical Trial Program
Genprex, Inc. (Nasdaq: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it entered into... 
From PR Newswire
Genprex (Nasdaq: GNPX) To Ring The Nasdaq Stock Market Closing Bell
Genprex, Inc. (Nasdaq: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer, based upon a novel proprietary technology platform, announced today that its management... 
From PR Newswire
42 Biggest Movers From Friday
Gainers Shoe Carnival, Inc. (NASDAQ: SCVL) shares gained 20.73 percent to close at $31.80 on Friday after the company ... 
Tags GROW BGSF FBIO
From Benzinga
Genprex To Present At Upcoming Investor And Industry Conferences
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that the management... 
From PR Newswire
45 Biggest Movers From Yesterday
Gainers Red Violet, Inc. (NASDAQ: RDVT) rose 75.31 percent to close at $9.94 after reporting Q1 results. Euro Tech ... 
Tags PFNX NETS HAIR
From Benzinga
48 Biggest Movers From Yesterday
Gainers Boxlight Corporation (NASDAQ: BOXL) shares jumped 77.44 percent to close at $11.80 on Monday. Integrated Media ... 
Tags ANFI ACIA HAIR
From Benzinga
36 Stocks Moving In Monday's Mid-Day Session
Gainers Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company ... 
Tags Movers & Shakers Markets Benzinga
From Benzinga
50 Biggest Movers From Friday
Gainers The Trade Desk, Inc. (NASDAQ: TTD) surged 43.39 percent to close at $75.61 on Friday after the company reported ... 
Tags CVG WPRT MYND
From Benzinga
55 Biggest Movers From Yesterday
Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares gained 67 percent to close at $49.80 after Eli Lilly and Company (NYSE: ... 
Tags SNCR LUNA HEAR
From Benzinga
53 Biggest Movers From Yesterday
Gainers ProPhase Labs, Inc. (NASDAQ: PRPH) climbed 54.56 percent to close at $4.47 on Tuesday after the company announced a ... 
Tags NIHD HTZ Trading Ideas
From Benzinga
Genprex Selects Accenture To Support Acceleration Of Oncoprex Clinical Development Program
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, has selected Accenture to provide... 
From PR Newswire
Genprex To Present At 2018 Disruptive Growth & Healthcare Conference
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that Rodney Varner,... 
From PR Newswire
Genprex Announces $10 Million Private Placement
Genprex, Inc. (NASDAQ: GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, announced today that it has entered... 
From PR Newswire
Don't Underestimate The Importance Of The First 5 Minutes Of The Trading Day
It’s strange to think that we’re more than a third of the way through 2018. And though I’m up more than $200k in my ... 
Tags Warrior Trading Benzinga General
From Benzinga
42 Biggest Movers From Yesterday
Gainers Heat Biologics, Inc. (NASDAQ: HTBX) shares jumped 94.86 percent to close at $4.17 on Tuesday. The nano-cap ... 
Tags HTBX RKDA Consumer Discretionary
From Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.